Guardant Health partners with Manulife to launch its Shield MCD blood test in Hong Kong, Singapore and the Philippines. Analysis of what this means for oncology.
Johnson & Johnson launches VARIPULSE pulsed field ablation technology in Peru. Discover what this means for atrial fibrillation treatment and electrophysiology innovation.
Convatec and Eakin Healthcare launch the eakin freeseal ostomy seal in the U.S. Discover what this means for leakage prevention and the evolving ostomy care market.
Seger Surgical Solutions Ltd., an Israel-based developer of minimally invasive surgical technologies, reported the successful completion of three first-in-human procedures using its SEGER IDEA laparoscopic bowel closure device during a clinical trial conducted at Zacamil Hospital in El Salvador. The procedures mark the first clinical use of the company’s device designed to perform bowel closure
New PREDICT-DNA data suggests ultrasensitive ctDNA monitoring may outperform traditional markers in breast cancer relapse prediction. Read the full analysis.
Firefly Neuroscience explores EEG brain wave biomarkers for ADHD subtype detection using AI. Discover how neurodiagnostics may reshape ADHD diagnosis.
Heru's PretestPro completes four ophthalmic pretests in under two minutes on a VR wearable. Explore what this means for clinic workflow and clinical validation. Read more.
Pulse Biosciences begins human study of nsPFA thyroid cancer treatment. Discover what this trial could mean for minimally invasive oncology.
Johnson & Johnson wins FDA approval for TECNIS PureSee IOL. Discover what this extended depth of focus cataract lens means for surgeons and patients.
C2N Diagnostics brings its PrecivityAD2 blood test to South Korea through BeauBrain Healthcare. Discover what this means for Alzheimer’s diagnosis.